Guangdong VTR Bio-Tech Co., Ltd.

¥5.31As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300381Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (15.11%)
Div yield 0.94%
ROE (1.25%)
Biotechnology
Beta (5Y) 0.38
PE TTM —
TSR TTM (23.59%)
Mkt cap ¥2.550B
ROIC (1.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.68
7.02%
35.53%
Hold 6|11|6|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.12
0.12
0.12
0.14
30.03%
11.91%
18.23%
21.22%
Revenue¥M
210.2
219.9
221.1
227.8
4.24%
8.86%
3.42%
6.99%
Peers (US$382.2M)
Cap (US$)
PE
374.4M
39.28x
Capital
TTM
5Y
10Y
Leveragex
6.865
0.099
0.068
EBIT/Intx
1.254
0.412
0.324
Own earn%
39.12
7.66
19.80
Sh yield%
14.43
33.92
40.74
Owners
Insiders/Inst%
13.02
77.86
Short interest%
5.60
SBC / revenue%
2.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
22–27
$1 testx
0.0
Incr. ROIC%
49